Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Syngenta Appoints New Chairman

October 17, 2012

BASEL, Switzerland, Oct. 18, 2012 /PRNewswire/ — Syngenta today announced the appointment of Michel Demare as the new Chairman of the Board with effect from the next Annual General Meeting on April 23, 2013. Mr. Demare will succeed Martin Taylor who, as previously announced, will retire from the Board on that date.

Martin Taylor said, “I am delighted that the Board has chosen Michel as my successor. Since his election as a Director earlier this year he has already made a significant contribution to Syngenta. His extensive international business experience makes him exceptionally well-qualified for the position. I look forward to working with him in the coming months to ensure a smooth transition.”

Syngenta is one of the world’s leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

Biography of Michel Demare:

Michel Demare has been Chief Financial Officer of ABB since 2005, serving in addition, between late 2008 and March 2011, as the company’s President of Global Markets. Between February and September 2008 he was ABB’s acting Chief Executive Officer. Previously he had been Chief Financial Officer Europe for Baxter International Inc. He joined Baxter in 2002 after 18 years in the Dow Chemical Company, where he held various treasury and business Chief Financial Officer positions in Europe (including Switzerland) and the US. He has been Vice Chairman of the Board of UBS since 2010, and is a member of the Board Committee of Swissholdings. He also serves on the Advisory Board of the Institut fur Banking und Finance of the University of Zurich and is a member of the IMD Foundation Board in Lausanne. A Belgian citizen, he holds an MBA from the Katholieke Universiteit of Leuven and has lived in Switzerland for 20 years.

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions.Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements.We refer you to Syngenta’s publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties.Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.

    Syngenta International AG           Media contact:               Analyst/Investor contact:

    Media Office                        Paul Barrett                 Jennifer Gough
    CH-4002 Basel                       Switzerland  +41 61 323 0597 Switzerland +41 61 323 5059
    Switzerland                                                      USA               +1 202 737 6521
    Tel:                +41 61 323 2323
    Fax:               +41 61 323 2424

    www.syngenta.com

SOURCE Syngenta


Source: PR Newswire